Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekBriefing
The sleep and respiratory giant completed the $340M Noctrix acquisition, adding a wearable neuromodulation tre…
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: …
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: …
The WeekSTAT News ↗
As the world deals with an outbreak of Ebola that has no known cure, Susan Reichle, who last year co-founded A…
The WeekAJMC ↗
Apalutamide Plus ADT Improves Outcomes in High-Risk Prostate Cancer: Mary-Ellen Taplin, MD…
The WeekBioPharma Dive ↗
Co-founded by longtime Alnylam CEO John Maraganore, City has brought a clotting disorder drug into early human…
The WeekFiercePharma ↗
The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiativ…
The WeekFierceBiotech ↗
Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK …
The WeekBriefing
Over half of eligible Medicare beneficiaries are now in Medicare Advantage, with growth concentrated in specia…
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: …
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: …
The WeekBioPharma Dive ↗
Racing the clock: How precision logistics deliver life-saving nuclear medicine.…
The WeekSTAT News ↗
"We do not lack cures. We lack the infrastructure to pay for and deliver them," writes William Padula.…
The WeekAJMC ↗
Bridging Science and Reality in Diabetes Care…
The WeekFiercePharma ↗
The company adjusted its full-year 2025 earnings to account for a legal provision of 402.5 billion JPY ($2.5 b…
The WeekFierceBiotech ↗
When it comes to turning T-cell therapies toward autoimmune diseases, CAR-Ts have been leading the way. But an…
The WeekBriefing
Three-quarters of Medicare Advantage enrollees pay no added premium in 2026, but rising out-of-pocket caps and…
The WeekSTAT News ↗
"Ebola is an unforgiving enemy," writes Tom Frieden, who led the U.S. CDC response to the 2014-2016 Ebola outb…
The WeekAJMC ↗
First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD…
The WeekBioPharma Dive ↗
A possible alternative to "anti-CGRP" medications, the drug didn't meet some analysts' expectations in mid-sta…
The WeekPharmaVoice ↗
While the large pharma's new drug Cobenfy has stumbled in schizophrenia, it could find new life in Alzheimer's…
The WeekPharmaVoice ↗
From hepatitis B to melanoma, recent study results show innovative approaches are gaining ground.…
The WeekFiercePharma ↗
With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its…
The WeekFierceBiotech ↗
On Thursday, the public had the first chance to air their grievances about the FDA's controversial Commissione…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.